Demonstrating ophthalmic bioequivalence: A comprehensive PK/PD Study Framework under FDA and EMA guidance with MIDD as an enabling tool
Crossref DOI link: https://doi.org/10.30574/wjarr.2026.29.3.0671
Published Online: 2026-03-31
Update policy: https://doi.org/10.30574/wjarr.ourcrossmarkpolicy
TAMIM, Mohamed Khalil